Johnson & Johnson expects an increase in demand for its cancer drugs. On Tuesday, Johnson & Johnson first quarterly report beat analysts’ estimate and raised its full-year sales forecast on the strength of a growing demand for its cancer drugs…. Read More ›
EPS
Here’s how the U.S. industry is going to benefit from the tax overhaul
The Republican-led overhaul of the U.S. tax code, a milestone in U.S. history, has direct and indirect benefits but the sectors that are likely to gain the most are highlighted below with notes from analysts. With the Republican-led U.S. House… Read More ›